PEGylated insulin Lispro (LY2605541): clinical overview of a new long-acting basal insulin analog in the treatment of Type 2 diabetes mellitus

Michael Einar Røder

PEGylated insulin Lispro (LY2605541): clinical overview of a new long-acting basal insulin analog in the treatment of Type 2 diabetes mellitus

Michael Einar Røder

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Expert Review of Endocrinology & Metabolism
Vol/bind	10
Udgave nummer	4
Sider (fra-til)	365-374
ISSN	1744-6651
Status	Udgivet - 2015

Citationsformater

@article{49a6c768c32a4a108456a59c858f3222,

title = "PEGylated insulin Lispro (LY2605541): clinical overview of a new long-acting basal insulin analog in the treatment of Type 2 diabetes mellitus",

author = "R{\o}der, {Michael Einar}",

year = "2015",

language = "English",

volume = "10",

pages = "365--374",

journal = "Expert Review of Endocrinology & Metabolism",

issn = "1744-6651",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - PEGylated insulin Lispro (LY2605541): clinical overview of a new long-acting basal insulin analog in the treatment of Type 2 diabetes mellitus

AU - Røder, Michael Einar

PY - 2015

Y1 - 2015

M3 - Journal article

SN - 1744-6651

VL - 10

SP - 365

EP - 374

JO - Expert Review of Endocrinology & Metabolism

JF - Expert Review of Endocrinology & Metabolism

IS - 4

ER -